Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trialSandra P. D’Angelo, Paul Nghiem|Journal for ImmunoTherapy of Cancer|2020Cited by 197
Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell CarcinomaShailender Bhatia, Paul Nghiem|Clinical Cancer Research|2019Cited by 89
Genetic Risk Factors for Early-Onset Merkel Cell CarcinomaNoreen Mohsin, Isaac Brownell, Kristina Lachance et al.|JAMA Dermatology|2024Cited by 14
33904 Early onset Merkel cell carcinoma in patients with XMEN diseaseNoreen Mohsin, Paul Nghiem, Austin J. Jabbour|Journal of the American Academy of Dermatology|2022Cited by 2
Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophyMichael J. Struharik, Xiaoqing Pan, Amanda K. Bettis et al.|UNC Libraries|2024Cited by 0